Confidential mandate

Market Risk Methodology Adviser

Planned Hiring / New

Market Risk Methodology Adviser mandate in New York, United States

Confidential Market Risk Methodology Adviser in New York, United States, reporting to the Board Risk Committee Chair. Advisory Quantitative Analysis appointment at Director-level Executive Adviser level, a 8-month mandate horizon; three days a week.

The mandate

This advisory appointment centres on a standing board question: do market-risk measures remain fit for the decisions attributed to them when market structure, portfolio behaviour and model limitations change? The Adviser will review selected methodology choices, performance evidence and limitation treatment. There is no line authority, model ownership or limit-approval power.

Three adviser days each week will cover a fortnightly technical session, monthly limitation review and one planned committee meeting. Management supplies methodology papers, performance analysis, exception records and its proposed disposition. The Adviser may recommend additional analysis, but will not reconstruct production, validate every model or author management’s papers.

Challenge will examine risk-factor coverage, horizon and liquidity assumptions, non-linearity, correlation, stressed calibration, proxy behaviour, back-testing exceptions and the relationship among complementary measures. The Adviser should make clear which decision a metric can support, where it becomes unreliable and what compensating information must accompany use.

The Board Risk Committee and accountable executives retain all choices. Advice will identify competing interpretations, decisive evidence and residual uncertainty. If management selects a different defensible response, the Adviser will document the rationale rather than claim an approval or assurance role.

At month eight, expected outputs are a sharper methodology-question framework, an indexed limitation agenda, improved exception papers and a record of committee dispositions. Conflicts involving financial positions, model suppliers, recent validation or assurance work and competing risk appointments must be cleared before detailed exposures are revealed.

What you will own

  • Assess whether each selected metric is aligned to its stated decision, holding period, confidence interpretation and portfolio behaviour.
  • Challenge risk-factor completeness, proxy selection and treatment of non-linear or illiquid exposures.
  • Review back-testing and exception analysis for root cause, statistical relevance and appropriate governance response.
  • Test stressed calibration, diversification and correlation assumptions against current limitations and observed behaviour.
  • Prepare concise questions that enable committee members to separate model output, uncertainty and management overlay.
  • Track accepted limitations, compensating measures, owners and expiry conditions through the advisory term.
  • Recommend independent validation or deeper investigation when advisory review is insufficient.
  • Decline model construction, production operation, limit setting and management approval requests.

Candidate qualifications

  • Demonstrate board-facing command of market-risk methodologies and the decisions they support.
  • Describe a metric that remained technically correct but became unsuitable for its asserted management use.
  • Show how a back-testing exception changed limitation, calibration or governance rather than being dismissed as noise.
  • Evidence challenge of proxies, liquidity horizons, correlations or non-linear exposure with quantitative support.
  • Explain how you communicated complementary measures without offering a false composite certainty.
  • Provide an example of influencing a material response while holding no executive authority.
  • Identify conflicts that could impair independent advice on market-risk methodology.

Working terms and boundaries

  • The monthly retainer buys three days weekly, fortnightly technical dialogue and scheduled monthly committee attendance.
  • Management provides complete approved analyses; the Adviser does not operate models or prepare production results.
  • There is no line authority, limit mandate, model approval, validation opinion or trading responsibility.
  • Additional event-driven attendance must displace scheduled work or be governed by a signed amendment.
  • Conflict screening occurs before positions, model providers or prior reviewers are named.

Application

Applications for this mandate are received in one way only: through the India Board Terminal's application process. It is automated end to end. Your Executive Passport travels to the mandate holder in its confidential form, your answers to the three questions below are read before anything else in your file, and every stage that follows is recorded on your applications page.

There is no address to write to and no intermediary to call. The mandate holder reads what the Terminal delivers and nothing else, which is what keeps the process the same for every applicant and keeps your name out of it until you release it. Applications close on 7 October 2026. Mandate reference QNT-ADV-2026-NYC-03.

More seats like this one

Every live mandate, by seat →

This mandate is confidential. The client is named only under a mutual NDA, and your own record is never listed, sold or shown to a company under your name until you release it for this specific mandate.